PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
102.27%
Net income growth above 1.5x TSM's 3.90%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-1.03%
Both reduce yoy D&A, with TSM at -0.80%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-116.41%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
0.76%
SBC growth of 0.76% while TSM is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
423.03%
Well above TSM's 464.20% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
1608.83%
AR growth of 1608.83% while TSM is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
-41.79%
Both reduce yoy inventory, with TSM at -82.54%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-205.04%
Negative yoy AP while TSM is 215.22%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
407.85%
Growth well above TSM's 255.73%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-3664.96%
Both negative yoy, with TSM at -66.59%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
104.86%
Operating cash flow growth above 1.5x TSM's 31.93%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
2.20%
Lower CapEx growth vs. TSM's 21.75%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
-20.26%
Both yoy lines negative, with TSM at -1414.54%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-19.17%
Both yoy lines are negative, with TSM at -72.17%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-287.02%
We reduce yoy other investing while TSM is 34.14%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-88.59%
We reduce yoy invests while TSM stands at 17.07%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-190.70%
We cut debt repayment yoy while TSM is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
178.34%
Issuance growth of 178.34% while TSM is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.